awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38294088-3C80FA58-DC3F-4DFE-9537-DB38E646882E
Q38294088-3C80FA58-DC3F-4DFE-9537-DB38E646882E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38294088-3C80FA58-DC3F-4DFE-9537-DB38E646882E
Potential role of rilotumumab in the treatment of gastric cancer.
P2860
Q38294088-3C80FA58-DC3F-4DFE-9537-DB38E646882E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38294088-3C80FA58-DC3F-4DFE-9537-DB38E646882E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
46788ee6aefc0270ac5553e4db2aef8e54b19b33
P2860
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer.